Gene Symbol | Gene ID | Gene Info |
---|---|---|
UBP1
|
ENSG00000153560.7 | upstream binding protein 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr3_33482816_33483024 | UBP1 | 841 | 0.652001 | -0.52 | 1.5e-01 | Click! |
chr3_33479481_33479632 | UBP1 | 1946 | 0.362866 | 0.40 | 2.8e-01 | Click! |
chr3_33482517_33482774 | UBP1 | 566 | 0.786834 | -0.37 | 3.3e-01 | Click! |
chr3_33482239_33482467 | UBP1 | 274 | 0.924857 | -0.29 | 4.5e-01 | Click! |
chr3_33483176_33483348 | UBP1 | 1183 | 0.521404 | 0.19 | 6.3e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr4_16899723_16900066 | 0.54 |
LDB2 |
LIM domain binding 2 |
291 |
0.95 |
chr12_108732762_108733103 | 0.50 |
CMKLR1 |
chemokine-like receptor 1 |
158 |
0.97 |
chr8_55294582_55295235 | 0.47 |
ENSG00000244107 |
. |
38120 |
0.17 |
chr7_707964_708478 | 0.43 |
PRKAR1B |
protein kinase, cAMP-dependent, regulatory, type I, beta |
23210 |
0.18 |
chr16_86602524_86602840 | 0.42 |
RP11-463O9.5 |
|
1315 |
0.34 |
chr17_79483816_79483967 | 0.40 |
RP13-766D20.2 |
|
2175 |
0.15 |
chr18_53069042_53069242 | 0.39 |
TCF4 |
transcription factor 4 |
60 |
0.98 |
chr17_2118811_2119625 | 0.39 |
AC130689.5 |
|
91 |
0.93 |
chr11_46300240_46300518 | 0.38 |
CREB3L1 |
cAMP responsive element binding protein 3-like 1 |
1151 |
0.46 |
chr19_36429057_36429287 | 0.38 |
LRFN3 |
leucine rich repeat and fibronectin type III domain containing 3 |
1150 |
0.32 |
chr8_120685095_120685496 | 0.37 |
ENPP2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
398 |
0.89 |
chr15_43810489_43810777 | 0.37 |
MAP1A |
microtubule-associated protein 1A |
810 |
0.55 |
chr7_120629708_120629973 | 0.36 |
CPED1 |
cadherin-like and PC-esterase domain containing 1 |
164 |
0.96 |
chr16_86603298_86603475 | 0.36 |
RP11-463O9.5 |
|
2019 |
0.25 |
chr6_136359084_136359592 | 0.36 |
RP13-143G15.3 |
|
26438 |
0.21 |
chr11_68780147_68780456 | 0.36 |
RP11-554A11.6 |
|
402 |
0.45 |
chr15_42749089_42749416 | 0.36 |
ZNF106 |
zinc finger protein 106 |
459 |
0.78 |
chr19_3606102_3607092 | 0.36 |
TBXA2R |
thromboxane A2 receptor |
61 |
0.89 |
chr13_100309968_100311087 | 0.35 |
ENSG00000263615 |
. |
15214 |
0.18 |
chr10_28287400_28288216 | 0.35 |
ARMC4 |
armadillo repeat containing 4 |
169 |
0.97 |
chr15_81081469_81081678 | 0.35 |
KIAA1199 |
KIAA1199 |
9861 |
0.22 |
chr2_200524119_200524534 | 0.35 |
SATB2 |
SATB homeobox 2 |
188337 |
0.03 |
chr5_179778925_179779076 | 0.35 |
GFPT2 |
glutamine-fructose-6-phosphate transaminase 2 |
900 |
0.63 |
chr8_27491561_27492240 | 0.34 |
SCARA3 |
scavenger receptor class A, member 3 |
202 |
0.93 |
chr18_72837219_72837938 | 0.34 |
ZADH2 |
zinc binding alcohol dehydrogenase domain containing 2 |
79890 |
0.11 |
chr15_48936460_48936718 | 0.33 |
FBN1 |
fibrillin 1 |
1329 |
0.57 |
chr4_71587677_71588145 | 0.33 |
RUFY3 |
RUN and FYVE domain containing 3 |
183 |
0.92 |
chr3_49237110_49237583 | 0.33 |
CCDC36 |
coiled-coil domain containing 36 |
403 |
0.74 |
chr13_76213824_76214088 | 0.33 |
LMO7 |
LIM domain 7 |
3497 |
0.21 |
chr20_30457693_30458808 | 0.33 |
DUSP15 |
dual specificity phosphatase 15 |
125 |
0.67 |
chr7_37960238_37961117 | 0.33 |
EPDR1 |
ependymin related 1 |
245 |
0.94 |
chr10_95241473_95241734 | 0.32 |
MYOF |
myoferlin |
348 |
0.88 |
chr2_216296824_216297216 | 0.32 |
FN1 |
fibronectin 1 |
3770 |
0.26 |
chr1_211813087_211813261 | 0.32 |
ENSG00000222080 |
. |
13717 |
0.17 |
chr12_91575790_91576058 | 0.32 |
DCN |
decorin |
505 |
0.87 |
chr8_122652743_122653011 | 0.31 |
HAS2-AS1 |
HAS2 antisense RNA 1 |
735 |
0.45 |
chr1_38412223_38412952 | 0.31 |
INPP5B |
inositol polyphosphate-5-phosphatase, 75kDa |
136 |
0.94 |
chr5_176798199_176798886 | 0.31 |
RGS14 |
regulator of G-protein signaling 14 |
4598 |
0.11 |
chr8_95273425_95273596 | 0.31 |
GEM |
GTP binding protein overexpressed in skeletal muscle |
512 |
0.85 |
chr17_9018882_9019405 | 0.30 |
NTN1 |
netrin 1 |
47109 |
0.15 |
chr5_71852937_71853195 | 0.30 |
ZNF366 |
zinc finger protein 366 |
49512 |
0.17 |
chr18_67068635_67069098 | 0.30 |
DOK6 |
docking protein 6 |
575 |
0.87 |
chr17_63555539_63556499 | 0.30 |
AXIN2 |
axin 2 |
395 |
0.91 |
chr8_77592906_77593199 | 0.30 |
ZFHX4 |
zinc finger homeobox 4 |
402 |
0.86 |
chr6_35182117_35182910 | 0.30 |
SCUBE3 |
signal peptide, CUB domain, EGF-like 3 |
317 |
0.9 |
chr6_33388329_33388490 | 0.30 |
SYNGAP1 |
synaptic Ras GTPase activating protein 1 |
377 |
0.74 |
chr15_62862079_62862274 | 0.30 |
TLN2 |
talin 2 |
8612 |
0.27 |
chr9_112876973_112877179 | 0.30 |
AKAP2 |
A kinase (PRKA) anchor protein 2 |
10705 |
0.28 |
chr10_3536975_3537238 | 0.30 |
RP11-184A2.3 |
|
256153 |
0.02 |
chr12_115105992_115106327 | 0.30 |
ENSG00000199220 |
. |
10292 |
0.22 |
chr8_37660027_37660381 | 0.30 |
GPR124 |
G protein-coupled receptor 124 |
5430 |
0.16 |
chrX_90690150_90690364 | 0.29 |
PABPC5-AS1 |
PABPC5 antisense RNA 1 |
259 |
0.68 |
chr3_184934142_184934696 | 0.29 |
ENSG00000264614 |
. |
36641 |
0.14 |
chr2_201473941_201474433 | 0.29 |
AOX1 |
aldehyde oxidase 1 |
21290 |
0.2 |
chr1_201858850_201859001 | 0.29 |
SHISA4 |
shisa family member 4 |
1089 |
0.38 |
chr1_201509679_201509830 | 0.29 |
CSRP1 |
cysteine and glycine-rich protein 1 |
31170 |
0.13 |
chr2_84743621_84743815 | 0.28 |
DNAH6 |
dynein, axonemal, heavy chain 6 |
139 |
0.98 |
chr10_104195566_104196022 | 0.28 |
ENSG00000202569 |
. |
475 |
0.64 |
chr9_27109543_27109972 | 0.28 |
TEK |
TEK tyrosine kinase, endothelial |
306 |
0.93 |
chr12_91572648_91572799 | 0.28 |
DCN |
decorin |
394 |
0.91 |
chr2_175546375_175546968 | 0.28 |
WIPF1 |
WAS/WASL interacting protein family, member 1 |
928 |
0.66 |
chr12_57526245_57526396 | 0.28 |
STAT6 |
signal transducer and activator of transcription 6, interleukin-4 induced |
398 |
0.73 |
chr9_130616224_130616383 | 0.28 |
ENG |
endoglin |
612 |
0.5 |
chr3_170136222_170136500 | 0.28 |
CLDN11 |
claudin 11 |
292 |
0.93 |
chr3_159628787_159629360 | 0.28 |
SCHIP1 |
schwannomin interacting protein 1 |
58345 |
0.11 |
chr1_86094810_86095135 | 0.28 |
ENSG00000199934 |
. |
37009 |
0.15 |
chr10_112258642_112259418 | 0.27 |
DUSP5 |
dual specificity phosphatase 5 |
1434 |
0.41 |
chr10_105421774_105421925 | 0.27 |
SH3PXD2A |
SH3 and PX domains 2A |
387 |
0.85 |
chr10_48439314_48439655 | 0.27 |
GDF10 |
growth differentiation factor 10 |
508 |
0.78 |
chr17_63549735_63549886 | 0.27 |
AXIN2 |
axin 2 |
5037 |
0.32 |
chrX_54947220_54948504 | 0.27 |
TRO |
trophinin |
41 |
0.97 |
chr12_57526448_57526635 | 0.27 |
STAT6 |
signal transducer and activator of transcription 6, interleukin-4 induced |
619 |
0.56 |
chr10_24497729_24498381 | 0.27 |
KIAA1217 |
KIAA1217 |
38 |
0.99 |
chr4_187645380_187645697 | 0.27 |
FAT1 |
FAT atypical cadherin 1 |
529 |
0.87 |
chr1_153854007_153854223 | 0.27 |
GATAD2B |
GATA zinc finger domain containing 2B |
41336 |
0.08 |
chr20_32850597_32850818 | 0.27 |
ASIP |
agouti signaling protein |
2536 |
0.24 |
chr3_183878422_183878793 | 0.27 |
DVL3 |
dishevelled segment polarity protein 3 |
4044 |
0.12 |
chr8_93074912_93075063 | 0.27 |
RUNX1T1 |
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
204 |
0.97 |
chr7_101376826_101377146 | 0.26 |
CUX1 |
cut-like homeobox 1 |
81973 |
0.09 |
chr2_27301899_27302732 | 0.26 |
EMILIN1 |
elastin microfibril interfacer 1 |
880 |
0.32 |
chr10_63213041_63213324 | 0.26 |
TMEM26 |
transmembrane protein 26 |
26 |
0.95 |
chr8_55087162_55087396 | 0.26 |
ENSG00000251835 |
. |
21837 |
0.2 |
chr15_26178696_26179227 | 0.26 |
ATP10A |
ATPase, class V, type 10A |
70606 |
0.1 |
chr2_120452671_120452885 | 0.26 |
TMEM177 |
transmembrane protein 177 |
15999 |
0.22 |
chr22_41957116_41957349 | 0.26 |
CSDC2 |
cold shock domain containing C2, RNA binding |
465 |
0.74 |
chr9_134165447_134165667 | 0.26 |
PPAPDC3 |
phosphatidic acid phosphatase type 2 domain containing 3 |
358 |
0.87 |
chr3_87035332_87035763 | 0.26 |
VGLL3 |
vestigial like 3 (Drosophila) |
4305 |
0.37 |
chr2_66667212_66667561 | 0.26 |
MEIS1-AS2 |
MEIS1 antisense RNA 2 |
58 |
0.86 |
chr14_100260916_100261174 | 0.26 |
EML1 |
echinoderm microtubule associated protein like 1 |
1273 |
0.55 |
chr15_39873424_39874712 | 0.26 |
THBS1 |
thrombospondin 1 |
774 |
0.66 |
chr3_12200610_12200790 | 0.26 |
TIMP4 |
TIMP metallopeptidase inhibitor 4 |
151 |
0.97 |
chr2_223657139_223657290 | 0.25 |
ACSL3 |
acyl-CoA synthetase long-chain family member 3 |
68438 |
0.11 |
chr12_298108_298329 | 0.25 |
RP11-283I3.1 |
|
3984 |
0.15 |
chr2_145278154_145278598 | 0.25 |
ZEB2-AS1 |
ZEB2 antisense RNA 1 |
203 |
0.55 |
chr7_39699230_39699381 | 0.25 |
RALA |
v-ral simian leukemia viral oncogene homolog A (ras related) |
35820 |
0.14 |
chr1_114521726_114521899 | 0.25 |
OLFML3 |
olfactomedin-like 3 |
251 |
0.91 |
chr13_33778604_33778877 | 0.25 |
STARD13 |
StAR-related lipid transfer (START) domain containing 13 |
1403 |
0.49 |
chr1_33160667_33160818 | 0.25 |
SYNC |
syncoilin, intermediate filament protein |
7619 |
0.14 |
chr2_145272420_145272698 | 0.25 |
ZEB2 |
zinc finger E-box binding homeobox 2 |
2556 |
0.32 |
chr4_77873265_77873416 | 0.25 |
SEPT11 |
septin 11 |
2325 |
0.36 |
chr16_75287131_75287498 | 0.25 |
BCAR1 |
breast cancer anti-estrogen resistance 1 |
1536 |
0.31 |
chr8_23567235_23567736 | 0.25 |
RP11-175E9.1 |
|
2831 |
0.22 |
chrX_99899847_99900028 | 0.25 |
SRPX2 |
sushi-repeat containing protein, X-linked 2 |
722 |
0.65 |
chrX_10851366_10851793 | 0.25 |
MID1 |
midline 1 (Opitz/BBB syndrome) |
183 |
0.97 |
chr1_93300512_93300663 | 0.25 |
ENSG00000206680 |
. |
2259 |
0.18 |
chr7_5734277_5734485 | 0.25 |
RNF216-IT1 |
RNF216 intronic transcript 1 (non-protein coding) |
14289 |
0.2 |
chr6_6737313_6737878 | 0.25 |
LY86-AS1 |
LY86 antisense RNA 1 |
114591 |
0.06 |
chr9_35688355_35688710 | 0.25 |
TPM2 |
tropomyosin 2 (beta) |
1368 |
0.2 |
chr10_671239_671508 | 0.25 |
RP11-809C18.3 |
|
3205 |
0.21 |
chr2_74230833_74231311 | 0.25 |
TET3 |
tet methylcytosine dioxygenase 3 |
1232 |
0.43 |
chr4_151505098_151505399 | 0.25 |
MAB21L2 |
mab-21-like 2 (C. elegans) |
2171 |
0.34 |
chr19_39862838_39862989 | 0.25 |
SAMD4B |
sterile alpha motif domain containing 4B |
2181 |
0.14 |
chr18_25756118_25756718 | 0.25 |
CDH2 |
cadherin 2, type 1, N-cadherin (neuronal) |
992 |
0.73 |
chr10_30459089_30459240 | 0.24 |
KIAA1462 |
KIAA1462 |
110711 |
0.06 |
chr4_153512671_153512904 | 0.24 |
ENSG00000268471 |
. |
55207 |
0.11 |
chr4_77665899_77666050 | 0.24 |
RP11-359D14.2 |
|
13653 |
0.22 |
chr5_43068261_43068432 | 0.24 |
ZNF131 |
zinc finger protein 131 |
187 |
0.87 |
chr17_71334494_71334713 | 0.24 |
CDC42EP4 |
CDC42 effector protein (Rho GTPase binding) 4 |
26289 |
0.18 |
chr5_14819136_14819289 | 0.24 |
ENSG00000264792 |
. |
6909 |
0.26 |
chr22_20790837_20791415 | 0.24 |
SCARF2 |
scavenger receptor class F, member 2 |
986 |
0.4 |
chr11_47279474_47279835 | 0.24 |
NR1H3 |
nuclear receptor subfamily 1, group H, member 3 |
105 |
0.94 |
chr1_79306379_79306727 | 0.24 |
ELTD1 |
EGF, latrophilin and seven transmembrane domain containing 1 |
77017 |
0.11 |
chr3_169529546_169530257 | 0.24 |
LRRC34 |
leucine rich repeat containing 34 |
551 |
0.61 |
chr1_230249813_230250036 | 0.24 |
GALNT2 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2) |
46906 |
0.16 |
chrX_152761685_152761943 | 0.24 |
HAUS7 |
HAUS augmin-like complex, subunit 7 |
836 |
0.41 |
chr8_69905704_69905881 | 0.24 |
ENSG00000238808 |
. |
117017 |
0.07 |
chr7_137671468_137671947 | 0.24 |
CREB3L2 |
cAMP responsive element binding protein 3-like 2 |
15086 |
0.19 |
chr20_44098779_44099661 | 0.24 |
WFDC2 |
WAP four-disulfide core domain 2 |
824 |
0.44 |
chr10_135073626_135073923 | 0.23 |
MIR202HG |
MIR202 host gene (non-protein coding) |
12379 |
0.1 |
chr2_174874655_174874956 | 0.23 |
SP3 |
Sp3 transcription factor |
44375 |
0.2 |
chr4_113739356_113739869 | 0.23 |
ANK2 |
ankyrin 2, neuronal |
347 |
0.9 |
chr6_118986087_118986317 | 0.23 |
CEP85L |
centrosomal protein 85kDa-like |
12519 |
0.29 |
chr16_72955387_72955672 | 0.23 |
ENSG00000221799 |
. |
63227 |
0.11 |
chr17_63590022_63590298 | 0.23 |
AXIN2 |
axin 2 |
32395 |
0.21 |
chr14_57274863_57275150 | 0.23 |
OTX2 |
orthodenticle homeobox 2 |
2160 |
0.26 |
chr9_18976340_18976597 | 0.23 |
FAM154A |
family with sequence similarity 154, member A |
56718 |
0.1 |
chr1_147013727_147014330 | 0.23 |
BCL9 |
B-cell CLL/lymphoma 9 |
846 |
0.72 |
chr19_485983_486314 | 0.23 |
MADCAM1 |
mucosal vascular addressin cell adhesion molecule 1 |
3028 |
0.13 |
chr17_80693481_80694097 | 0.23 |
FN3K |
fructosamine 3 kinase |
338 |
0.79 |
chr15_65197450_65197821 | 0.23 |
ENSG00000264929 |
. |
5197 |
0.16 |
chr5_143584982_143585179 | 0.23 |
KCTD16 |
potassium channel tetramerization domain containing 16 |
240 |
0.95 |
chr7_20638496_20638708 | 0.23 |
ABCB5 |
ATP-binding cassette, sub-family B (MDR/TAP), member 5 |
16228 |
0.29 |
chr1_60599792_60599943 | 0.23 |
C1orf87 |
chromosome 1 open reading frame 87 |
60425 |
0.15 |
chr9_130615735_130616098 | 0.23 |
ENG |
endoglin |
999 |
0.31 |
chr7_79083903_79084103 | 0.23 |
ENSG00000234456 |
. |
672 |
0.6 |
chr3_124493505_124493670 | 0.23 |
ITGB5-AS1 |
ITGB5 antisense RNA 1 |
6415 |
0.18 |
chr1_63154122_63154664 | 0.23 |
RP11-230B22.1 |
|
240 |
0.69 |
chr5_143171818_143172301 | 0.23 |
HMHB1 |
histocompatibility (minor) HB-1 |
19667 |
0.27 |
chr9_118918844_118919316 | 0.23 |
PAPPA |
pregnancy-associated plasma protein A, pappalysin 1 |
2997 |
0.34 |
chr2_66808823_66809387 | 0.23 |
MEIS1 |
Meis homeobox 1 |
73046 |
0.12 |
chr5_108475290_108475441 | 0.23 |
ENSG00000206593 |
. |
124724 |
0.06 |
chr15_78357987_78358461 | 0.23 |
TBC1D2B |
TBC1 domain family, member 2B |
241 |
0.89 |
chr9_96717847_96718052 | 0.22 |
BARX1 |
BARX homeobox 1 |
295 |
0.94 |
chrX_130964358_130965005 | 0.22 |
ENSG00000200587 |
. |
108303 |
0.07 |
chr12_27674030_27674262 | 0.22 |
PPFIBP1 |
PTPRF interacting protein, binding protein 1 (liprin beta 1) |
2218 |
0.35 |
chr8_131960988_131961496 | 0.22 |
RP11-737F9.1 |
|
13587 |
0.24 |
chr12_77272013_77272805 | 0.22 |
CSRP2 |
cysteine and glycine-rich protein 2 |
356 |
0.56 |
chr5_148787363_148787711 | 0.22 |
ENSG00000208035 |
. |
20944 |
0.11 |
chr4_100815773_100816143 | 0.22 |
LAMTOR3 |
late endosomal/lysosomal adaptor, MAPK and MTOR activator 3 |
311 |
0.91 |
chr15_73979749_73979900 | 0.22 |
CD276 |
CD276 molecule |
2477 |
0.33 |
chr2_110872434_110873339 | 0.22 |
MALL |
mal, T-cell differentiation protein-like |
713 |
0.63 |
chr12_68041813_68042274 | 0.22 |
DYRK2 |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 |
75 |
0.98 |
chr2_100722349_100722500 | 0.22 |
AFF3 |
AF4/FMR2 family, member 3 |
85 |
0.95 |
chr22_20119477_20120671 | 0.22 |
ZDHHC8 |
zinc finger, DHHC-type containing 8 |
603 |
0.53 |
chr6_158046741_158046923 | 0.22 |
ZDHHC14 |
zinc finger, DHHC-type containing 14 |
32791 |
0.21 |
chr12_49526829_49526998 | 0.22 |
ENSG00000200309 |
. |
183 |
0.86 |
chr2_12859088_12859514 | 0.22 |
TRIB2 |
tribbles pseudokinase 2 |
937 |
0.67 |
chr1_9262322_9262703 | 0.22 |
H6PD |
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) |
32322 |
0.15 |
chr1_75138923_75139762 | 0.22 |
C1orf173 |
chromosome 1 open reading frame 173 |
80 |
0.98 |
chr12_92964011_92964176 | 0.22 |
ENSG00000238865 |
. |
25330 |
0.23 |
chr12_26112779_26113361 | 0.22 |
RASSF8-AS1 |
RASSF8 atnisense RNA 1 |
372 |
0.8 |
chr8_91554264_91554415 | 0.22 |
ENSG00000199354 |
. |
30983 |
0.2 |
chr16_16092499_16092731 | 0.22 |
ABCC1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
11098 |
0.24 |
chr1_170667661_170668226 | 0.22 |
PRRX1 |
paired related homeobox 1 |
34865 |
0.22 |
chr1_53068469_53068939 | 0.22 |
GPX7 |
glutathione peroxidase 7 |
660 |
0.7 |
chr19_38700522_38700866 | 0.22 |
ENSG00000266428 |
. |
9820 |
0.1 |
chr17_17862779_17863058 | 0.22 |
TOM1L2 |
target of myb1-like 2 (chicken) |
12793 |
0.15 |
chr2_121304112_121304467 | 0.22 |
LINC01101 |
long intergenic non-protein coding RNA 1101 |
80592 |
0.1 |
chr3_72319089_72319240 | 0.22 |
ENSG00000212070 |
. |
7585 |
0.32 |
chr2_18300931_18301082 | 0.22 |
ENSG00000212455 |
. |
79007 |
0.12 |
chr16_19894763_19895346 | 0.22 |
GPRC5B |
G protein-coupled receptor, family C, group 5, member B |
1132 |
0.51 |
chr6_28457374_28458144 | 0.22 |
GPX6 |
glutathione peroxidase 6 (olfactory) |
25805 |
0.14 |
chr18_12416010_12416161 | 0.22 |
SLMO1 |
slowmo homolog 1 (Drosophila) |
3806 |
0.19 |
chr15_55881115_55881360 | 0.22 |
PYGO1 |
pygopus family PHD finger 1 |
92 |
0.98 |
chr1_170634990_170635141 | 0.22 |
PRRX1 |
paired related homeobox 1 |
1987 |
0.46 |
chr4_57931934_57932158 | 0.21 |
ENSG00000238541 |
. |
40465 |
0.11 |
chr1_6551002_6551374 | 0.21 |
PLEKHG5 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
548 |
0.66 |
chr3_37114235_37114598 | 0.21 |
LRRFIP2 |
leucine rich repeat (in FLII) interacting protein 2 |
10825 |
0.17 |
chr11_102600844_102600995 | 0.21 |
MMP8 |
matrix metallopeptidase 8 (neutrophil collagenase) |
5234 |
0.16 |
chr2_122353801_122354268 | 0.21 |
ENSG00000222467 |
. |
6706 |
0.21 |
chr6_4607096_4607567 | 0.21 |
ENSG00000238801 |
. |
36665 |
0.21 |
chr1_47108744_47108895 | 0.21 |
ATPAF1 |
ATP synthase mitochondrial F1 complex assembly factor 1 |
2109 |
0.24 |
chr8_13371978_13372169 | 0.21 |
DLC1 |
deleted in liver cancer 1 |
201 |
0.95 |
chr6_107816329_107816751 | 0.21 |
SOBP |
sine oculis binding protein homolog (Drosophila) |
5378 |
0.23 |
chr11_119292436_119293234 | 0.21 |
THY1 |
Thy-1 cell surface antigen |
437 |
0.74 |
chr3_30537822_30538024 | 0.21 |
TGFBR2 |
transforming growth factor, beta receptor II (70/80kDa) |
110071 |
0.07 |
chr20_45338822_45338973 | 0.21 |
SLC2A10 |
solute carrier family 2 (facilitated glucose transporter), member 10 |
771 |
0.66 |
chr6_157610005_157610158 | 0.21 |
ENSG00000252609 |
. |
102350 |
0.07 |
chr1_201508596_201509227 | 0.21 |
CSRP1 |
cysteine and glycine-rich protein 1 |
30327 |
0.13 |
chr19_47200993_47201192 | 0.21 |
ENSG00000243560 |
. |
8767 |
0.09 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.0 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 0.7 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.2 | 0.6 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) substrate-dependent cerebral cortex tangential migration(GO:0021825) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.2 | 0.5 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.2 | 0.5 | GO:0060596 | mammary placode formation(GO:0060596) |
0.2 | 0.5 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.4 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.1 | 0.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.4 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 0.4 | GO:0071694 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.1 | 0.4 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.1 | 0.4 | GO:0070932 | histone H3 deacetylation(GO:0070932) histone H4 deacetylation(GO:0070933) |
0.1 | 0.3 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.1 | 0.4 | GO:0048293 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
0.1 | 0.2 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.1 | 0.2 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.1 | 0.2 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.1 | 0.7 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.1 | 0.3 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.1 | 0.3 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.2 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.1 | 0.6 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.3 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.5 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.1 | 0.3 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.1 | 0.4 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.3 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
0.1 | 0.1 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
0.1 | 0.3 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.3 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.1 | 0.1 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.1 | 0.2 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.1 | 0.3 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.1 | 0.1 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.1 | 0.1 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.1 | 0.3 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.1 | 0.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 0.3 | GO:0061042 | vascular wound healing(GO:0061042) regulation of vascular wound healing(GO:0061043) |
0.1 | 0.4 | GO:0071674 | mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
0.1 | 0.2 | GO:0008049 | male courtship behavior(GO:0008049) |
0.1 | 0.2 | GO:0060437 | lung growth(GO:0060437) |
0.1 | 0.3 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.1 | 1.2 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.1 | 0.3 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.1 | 0.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.2 | GO:0051832 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.1 | 0.1 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.1 | 0.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.1 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.1 | 0.4 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.1 | 0.1 | GO:0055057 | neuronal stem cell division(GO:0036445) neuroblast division(GO:0055057) |
0.1 | 0.2 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.2 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.1 | 0.2 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.2 | GO:0002669 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) positive regulation of T cell anergy(GO:0002669) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 0.1 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.1 | 0.1 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 0.3 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 0.3 | GO:2000095 | regulation of non-canonical Wnt signaling pathway(GO:2000050) regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 | 0.1 | GO:0021860 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.1 | 0.1 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.1 | 0.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.7 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.1 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.1 | 0.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.1 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
0.1 | 0.2 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.2 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 0.2 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.2 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.2 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.1 | 0.1 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.1 | 0.3 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.1 | 0.5 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.1 | 0.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.5 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.1 | 0.2 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.1 | 0.1 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
0.1 | 0.3 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.2 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 0.4 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.3 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.2 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 0.2 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.1 | 0.2 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.1 | 0.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.1 | GO:0090197 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
0.1 | 0.3 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.1 | 0.1 | GO:0060913 | cardiac cell fate determination(GO:0060913) |
0.1 | 0.1 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.1 | 0.2 | GO:0009169 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 0.2 | GO:0046618 | drug export(GO:0046618) |
0.1 | 0.2 | GO:0008354 | germ cell migration(GO:0008354) |
0.0 | 0.2 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 0.1 | GO:0061687 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
0.0 | 0.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.1 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.0 | 0.3 | GO:0031641 | regulation of myelination(GO:0031641) |
0.0 | 0.1 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.0 | 0.1 | GO:0060343 | trabecula formation(GO:0060343) heart trabecula formation(GO:0060347) trabecula morphogenesis(GO:0061383) heart trabecula morphogenesis(GO:0061384) |
0.0 | 0.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.1 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.2 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.0 | 0.2 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.0 | 1.2 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.8 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.1 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
0.0 | 0.1 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.0 | 0.1 | GO:0048641 | regulation of skeletal muscle tissue development(GO:0048641) |
0.0 | 0.1 | GO:0048557 | embryonic digestive tract morphogenesis(GO:0048557) |
0.0 | 0.1 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.0 | 0.2 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.0 | 0.3 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.0 | 0.1 | GO:0060992 | response to fungicide(GO:0060992) |
0.0 | 0.2 | GO:0046398 | UDP-glucuronate metabolic process(GO:0046398) |
0.0 | 0.3 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.0 | 0.1 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.0 | 0.1 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.0 | 0.1 | GO:0061430 | bone trabecula formation(GO:0060346) bone trabecula morphogenesis(GO:0061430) |
0.0 | 0.2 | GO:0051665 | membrane raft localization(GO:0051665) |
0.0 | 0.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.0 | 0.3 | GO:0030238 | male sex determination(GO:0030238) |
0.0 | 0.3 | GO:0002040 | sprouting angiogenesis(GO:0002040) |
0.0 | 0.1 | GO:0034201 | response to oleic acid(GO:0034201) |
0.0 | 0.1 | GO:1903053 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.0 | 0.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.0 | 0.2 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.0 | 0.2 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.0 | 0.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.0 | 0.2 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.1 | GO:0090026 | regulation of monocyte chemotaxis(GO:0090025) positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.1 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.0 | 0.0 | GO:0014742 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.0 | 0.1 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.0 | 0.1 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) |
0.0 | 0.2 | GO:0060088 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.0 | 0.1 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.0 | 0.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.0 | 0.1 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.1 | GO:0003032 | detection of oxygen(GO:0003032) |
0.0 | 0.1 | GO:0010834 | obsolete telomere maintenance via telomere shortening(GO:0010834) |
0.0 | 0.0 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.0 | 0.1 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.0 | 0.0 | GO:0032347 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) negative regulation of hormone metabolic process(GO:0032351) negative regulation of hormone biosynthetic process(GO:0032353) |
0.0 | 0.3 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.2 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.0 | 0.2 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.0 | 0.0 | GO:0060602 | branch elongation of an epithelium(GO:0060602) |
0.0 | 0.2 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.0 | 0.1 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.0 | 0.2 | GO:0015904 | tetracycline transport(GO:0015904) |
0.0 | 0.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.1 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.0 | 0.0 | GO:0085029 | extracellular matrix assembly(GO:0085029) |
0.0 | 0.0 | GO:0071025 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.0 | 0.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.0 | 0.1 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.0 | 0.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.0 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.0 | 0.0 | GO:0060083 | urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) micturition(GO:0060073) smooth muscle contraction involved in micturition(GO:0060083) |
0.0 | 0.1 | GO:0048245 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.0 | 0.1 | GO:0090116 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.0 | 0.0 | GO:0042504 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
0.0 | 0.2 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.1 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.0 | 0.5 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.0 | 0.1 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.0 | 0.1 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.0 | 0.1 | GO:0016999 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.0 | 0.0 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.0 | 0.3 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.0 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) regulation of steroid hormone biosynthetic process(GO:0090030) |
0.0 | 0.1 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.0 | 0.0 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.0 | 0.1 | GO:0006530 | asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
0.0 | 0.1 | GO:0072583 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.0 | 0.1 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.0 | 0.1 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
0.0 | 0.3 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.0 | 0.0 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.0 | 0.0 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
0.0 | 0.2 | GO:0044851 | hair cycle phase(GO:0044851) hair follicle maturation(GO:0048820) |
0.0 | 0.1 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.0 | 0.1 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 0.2 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.1 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) regulation of pigment cell differentiation(GO:0050932) |
0.0 | 0.1 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.0 | 0.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.1 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.0 | 0.3 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.1 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.0 | 0.2 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.0 | 0.0 | GO:0002890 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
0.0 | 0.1 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.0 | 0.1 | GO:0009111 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.0 | 0.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.1 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.0 | 0.0 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.0 | 0.1 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.0 | 0.0 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.0 | 0.2 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.0 | 0.0 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.0 | 0.1 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.0 | 0.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.1 | GO:0031427 | response to methotrexate(GO:0031427) |
0.0 | 0.2 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.0 | GO:0002887 | negative regulation of myeloid leukocyte mediated immunity(GO:0002887) negative regulation of leukocyte degranulation(GO:0043301) |
0.0 | 0.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.1 | GO:0009648 | photoperiodism(GO:0009648) |
0.0 | 0.4 | GO:0035136 | forelimb morphogenesis(GO:0035136) |
0.0 | 0.1 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.2 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.1 | GO:0010761 | fibroblast migration(GO:0010761) |
0.0 | 0.0 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.0 | 0.1 | GO:0097094 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.0 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.0 | 0.1 | GO:0045920 | negative regulation of exocytosis(GO:0045920) |
0.0 | 0.0 | GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway(GO:0090081) |
0.0 | 0.1 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.0 | 0.1 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.0 | 0.0 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.0 | 0.3 | GO:0048535 | lymph node development(GO:0048535) |
0.0 | 0.1 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.1 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.0 | 0.1 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.0 | 0.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.1 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.0 | 0.2 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) positive regulation of glycogen metabolic process(GO:0070875) |
0.0 | 0.1 | GO:0031659 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.0 | 0.0 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.0 | 0.0 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.0 | 0.3 | GO:0051322 | anaphase(GO:0051322) |
0.0 | 0.2 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.0 | 0.0 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.0 | 0.1 | GO:0016246 | RNA interference(GO:0016246) |
0.0 | 0.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.0 | 0.4 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.1 | GO:0043368 | positive T cell selection(GO:0043368) |
0.0 | 0.1 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
0.0 | 0.1 | GO:0009744 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.0 | 0.2 | GO:0015840 | urea transport(GO:0015840) |
0.0 | 0.2 | GO:0060349 | bone morphogenesis(GO:0060349) |
0.0 | 0.3 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
0.0 | 0.1 | GO:0014824 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.0 | 0.2 | GO:0010171 | body morphogenesis(GO:0010171) |
0.0 | 0.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.4 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
0.0 | 0.0 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.0 | 0.0 | GO:0070091 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
0.0 | 0.1 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.0 | 0.1 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.0 | 0.1 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.1 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.1 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.0 | 0.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.0 | 0.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.0 | GO:0033088 | regulation of immature T cell proliferation in thymus(GO:0033084) negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.0 | 0.1 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.0 | 0.0 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.0 | 0.5 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.0 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.1 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.0 | 0.0 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.0 | 0.0 | GO:0031111 | negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
0.0 | 0.1 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 0.1 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.2 | GO:0071445 | obsolete cellular response to protein stimulus(GO:0071445) |
0.0 | 0.1 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.0 | 0.0 | GO:1901798 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.0 | 0.0 | GO:0072193 | positive regulation of smooth muscle cell differentiation(GO:0051152) ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
0.0 | 0.0 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.0 | 0.0 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.0 | 0.1 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.1 | GO:0080111 | DNA demethylation(GO:0080111) |
0.0 | 0.0 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.2 | GO:0051875 | melanosome localization(GO:0032400) pigment granule localization(GO:0051875) |
0.0 | 0.1 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.0 | 0.0 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.0 | 0.1 | GO:0032506 | cytokinetic process(GO:0032506) |
0.0 | 0.2 | GO:2000738 | positive regulation of stem cell differentiation(GO:2000738) |
0.0 | 0.1 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.0 | 0.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.1 | GO:0006573 | valine metabolic process(GO:0006573) |
0.0 | 0.1 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.0 | 0.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.2 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.0 | 0.0 | GO:0009261 | ribonucleotide catabolic process(GO:0009261) |
0.0 | 0.1 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.0 | 0.1 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.0 | GO:0052251 | induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) |
0.0 | 0.1 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.0 | 0.1 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.0 | 0.1 | GO:0048636 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
0.0 | 0.0 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.1 | GO:2000144 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.1 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.0 | 0.1 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.0 | 0.0 | GO:2000300 | regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
0.0 | 0.1 | GO:0051145 | smooth muscle cell differentiation(GO:0051145) |
0.0 | 0.7 | GO:0030198 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.0 | 0.1 | GO:0043113 | receptor clustering(GO:0043113) |
0.0 | 0.0 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.0 | 0.0 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.1 | GO:0032372 | negative regulation of sterol transport(GO:0032372) negative regulation of cholesterol transport(GO:0032375) |
0.0 | 0.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.0 | 0.1 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.0 | 0.2 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.1 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.0 | 0.1 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.0 | 0.4 | GO:0051101 | regulation of DNA binding(GO:0051101) |
0.0 | 0.0 | GO:0044091 | membrane biogenesis(GO:0044091) |
0.0 | 0.0 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.0 | 0.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.2 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.0 | 0.1 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.0 | 0.2 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.0 | 0.0 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.0 | 0.1 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.0 | 0.1 | GO:0042819 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.0 | 0.7 | GO:0007612 | learning(GO:0007612) |
0.0 | 0.0 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.0 | 0.0 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.0 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.0 | 0.2 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.1 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.0 | 0.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.0 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.0 | 0.0 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.0 | 0.2 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.0 | 0.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.1 | GO:0045821 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) positive regulation of ATP metabolic process(GO:1903580) |
0.0 | 0.0 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.0 | 0.3 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.1 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.2 | GO:0070633 | transepithelial transport(GO:0070633) |
0.0 | 0.1 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.0 | 0.1 | GO:0045686 | negative regulation of glial cell differentiation(GO:0045686) negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.0 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.0 | 0.1 | GO:0010587 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
0.0 | 0.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.1 | GO:0014904 | myotube cell development(GO:0014904) |
0.0 | 0.0 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.0 | 0.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.1 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.0 | 0.1 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.0 | 0.0 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.2 | GO:0009268 | response to pH(GO:0009268) |
0.0 | 0.2 | GO:0032456 | endocytic recycling(GO:0032456) |
0.0 | 0.1 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.0 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.1 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.1 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.0 | 0.1 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.0 | 0.0 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.0 | 0.0 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.1 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.0 | 0.1 | GO:0007530 | sex determination(GO:0007530) |
0.0 | 0.2 | GO:0030818 | negative regulation of cAMP metabolic process(GO:0030815) negative regulation of cAMP biosynthetic process(GO:0030818) |
0.0 | 0.2 | GO:0046677 | response to antibiotic(GO:0046677) |
0.0 | 0.1 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.0 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.0 | 0.1 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.0 | 0.1 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.0 | 0.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.1 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.0 | 0.0 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.0 | 0.0 | GO:1900078 | positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.0 | 0.0 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.0 | 0.0 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.0 | 0.2 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.0 | 0.1 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.0 | 0.0 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.0 | 0.1 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
0.0 | 0.0 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.1 | GO:0048536 | spleen development(GO:0048536) |
0.0 | 0.0 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 0.0 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.0 | 0.0 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.0 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.0 | 0.2 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.0 | 0.1 | GO:0070265 | necrotic cell death(GO:0070265) |
0.0 | 0.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.2 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.0 | GO:0071800 | podosome assembly(GO:0071800) |
0.0 | 0.2 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.0 | 0.1 | GO:0046051 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) UTP metabolic process(GO:0046051) |
0.0 | 0.0 | GO:0031646 | positive regulation of neurological system process(GO:0031646) positive regulation of transmission of nerve impulse(GO:0051971) |
0.0 | 0.1 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 0.0 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.0 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.2 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.0 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.0 | 0.1 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.0 | 0.0 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.0 | 0.0 | GO:0055094 | response to lipoprotein particle(GO:0055094) |
0.0 | 0.0 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.1 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.1 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.0 | 0.1 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.0 | GO:0021955 | central nervous system projection neuron axonogenesis(GO:0021952) central nervous system neuron axonogenesis(GO:0021955) |
0.0 | 1.5 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.0 | GO:1901070 | guanosine-containing compound biosynthetic process(GO:1901070) |
0.0 | 0.1 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.2 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.0 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.0 | 0.0 | GO:0034661 | ncRNA catabolic process(GO:0034661) |
0.0 | 0.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.2 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.0 | GO:0044068 | modulation by virus of host process(GO:0019054) modulation by symbiont of host cellular process(GO:0044068) |
0.0 | 0.0 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.0 | 0.1 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.0 | 0.1 | GO:0045008 | depyrimidination(GO:0045008) |
0.0 | 0.0 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.1 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.0 | 0.2 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.0 | 0.1 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.0 | 0.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.1 | GO:0018202 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.0 | 0.0 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.0 | 0.1 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.0 | 0.0 | GO:0031167 | rRNA methylation(GO:0031167) |
0.0 | 0.0 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.2 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.0 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.0 | 0.0 | GO:0031579 | membrane raft organization(GO:0031579) |
0.0 | 0.1 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.0 | 0.1 | GO:0061647 | histone H3-K9 methylation(GO:0051567) histone H3-K9 modification(GO:0061647) |
0.0 | 0.1 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.0 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 0.1 | GO:0010524 | positive regulation of calcium ion transport into cytosol(GO:0010524) |
0.0 | 1.2 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
0.0 | 0.0 | GO:0016139 | glycoside metabolic process(GO:0016137) glycoside catabolic process(GO:0016139) |
0.0 | 0.0 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.0 | 0.0 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.1 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.0 | 0.0 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.1 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.0 | GO:0002320 | lymphoid progenitor cell differentiation(GO:0002320) |
0.0 | 0.0 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.0 | 0.0 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.0 | 0.1 | GO:0048278 | vesicle docking(GO:0048278) |
0.0 | 0.1 | GO:0009083 | branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.0 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.0 | GO:1903513 | endoplasmic reticulum to cytosol transport(GO:1903513) |
0.0 | 0.0 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.0 | 0.0 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.0 | 0.0 | GO:1901984 | negative regulation of histone acetylation(GO:0035067) negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.0 | 0.0 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 0.0 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.1 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.0 | 0.2 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.0 | 0.0 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) negative regulation of B cell differentiation(GO:0045578) |
0.0 | 0.1 | GO:0006895 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.0 | 0.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.0 | 0.0 | GO:0000089 | mitotic metaphase(GO:0000089) |
0.0 | 0.1 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.0 | 0.0 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.0 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.1 | GO:0072666 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.0 | 0.0 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.1 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.0 | 0.0 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.0 | 0.0 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.1 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.0 | 0.1 | GO:0002027 | regulation of heart rate(GO:0002027) |
0.0 | 0.0 | GO:0001554 | luteolysis(GO:0001554) |
0.0 | 0.0 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.0 | 0.0 | GO:0000470 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.0 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.0 | 0.0 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.3 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 0.4 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.5 | GO:0032059 | bleb(GO:0032059) |
0.1 | 0.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 0.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.3 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.2 | GO:0043657 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 0.1 | GO:0044447 | axoneme part(GO:0044447) |
0.1 | 0.2 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 0.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.5 | GO:0030122 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.1 | 0.5 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 0.3 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.1 | 0.3 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.3 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.0 | 1.3 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.0 | 0.1 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.0 | 0.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.3 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.0 | 0.2 | GO:0002178 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 0.3 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.1 | GO:0016939 | kinesin II complex(GO:0016939) |
0.0 | 0.1 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.0 | 0.3 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.2 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.0 | 0.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.1 | GO:0071437 | invadopodium(GO:0071437) |
0.0 | 0.1 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.4 | GO:0031105 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.0 | 0.3 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.3 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 0.2 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.2 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 0.1 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.0 | 0.1 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.1 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.0 | 0.1 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.1 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.0 | 0.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.3 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.8 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.4 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.1 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.0 | 0.4 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 1.1 | GO:0005901 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
0.0 | 0.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.0 | GO:0030118 | clathrin coat(GO:0030118) |
0.0 | 0.1 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.3 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 0.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.0 | 0.1 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.1 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 0.1 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 0.1 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.5 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.1 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.0 | 0.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.1 | GO:0044291 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.0 | 0.1 | GO:0008278 | cohesin complex(GO:0008278) |
0.0 | 0.1 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.0 | 0.8 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 0.0 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.0 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.0 | 0.2 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.0 | 0.6 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.0 | 0.0 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.0 | 0.1 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 0.4 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 3.8 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 0.1 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.1 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.0 | 0.7 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.0 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.0 | 0.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.1 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 0.0 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.1 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.1 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.0 | 0.0 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.0 | 0.0 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.1 | GO:0030120 | vesicle coat(GO:0030120) |
0.0 | 0.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.1 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 0.0 | GO:0030288 | outer membrane-bounded periplasmic space(GO:0030288) periplasmic space(GO:0042597) |
0.0 | 0.0 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.0 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.0 | 0.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.4 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 0.0 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.0 | 0.1 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.0 | 0.0 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.3 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.8 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.0 | 0.0 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 0.0 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.1 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.1 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.0 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.0 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.1 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.3 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.2 | 1.4 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.1 | 0.4 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.1 | 0.4 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.8 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.3 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.1 | 0.2 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.1 | 0.7 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.5 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 0.4 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.1 | 0.4 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.1 | 0.3 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.3 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.1 | 0.8 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 0.3 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.1 | 0.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.6 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.3 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.2 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.2 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.1 | 0.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.2 | GO:0097493 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.3 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 1.4 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.2 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 0.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.1 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 0.2 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.1 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.2 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.1 | 0.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.4 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.1 | 0.2 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 0.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.5 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.2 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.2 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.2 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.1 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.2 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.0 | 0.3 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.0 | 0.2 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.0 | 0.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.4 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.0 | 0.5 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.5 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.0 | 0.0 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.1 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.0 | 0.4 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 0.2 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.0 | 0.1 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.0 | 0.2 | GO:0098988 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.0 | 0.1 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.2 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.3 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.2 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.2 | GO:0043559 | insulin binding(GO:0043559) |
0.0 | 0.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.1 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.0 | 0.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.0 | 0.3 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.0 | 0.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.3 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.2 | GO:0051192 | ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process(GO:0000036) ACP phosphopantetheine attachment site binding(GO:0044620) prosthetic group binding(GO:0051192) |
0.0 | 0.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.0 | 1.0 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.0 | 0.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 1.0 | GO:0046332 | SMAD binding(GO:0046332) |
0.0 | 0.2 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.3 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.0 | 0.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.3 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.0 | 0.5 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) protein tyrosine kinase binding(GO:1990782) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.3 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.3 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.1 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.0 | 0.6 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.0 | 0.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.1 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.0 | 0.2 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.0 | 0.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.1 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.0 | 0.1 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.0 | 0.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.2 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.0 | 0.5 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 0.5 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.0 | 0.2 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.1 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.0 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 0.2 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.0 | 0.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.0 | 0.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.3 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.1 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.0 | 0.2 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.2 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.0 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.2 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.2 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.5 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.2 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.4 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.6 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.2 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.3 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.0 | 0.2 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.0 | 0.0 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.0 | 0.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.0 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.4 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 1.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.0 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.0 | 0.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 0.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.0 | 0.1 | GO:0004675 | transmembrane receptor protein serine/threonine kinase activity(GO:0004675) |
0.0 | 0.1 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.1 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.0 | 0.1 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.0 | 0.1 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.1 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.0 | 0.1 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.0 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.1 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.1 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.0 | 0.1 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.0 | 0.2 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.2 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.0 | GO:0043176 | amine binding(GO:0043176) |
0.0 | 0.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.2 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.1 | GO:0003896 | DNA primase activity(GO:0003896) |
0.0 | 0.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.2 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.1 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.0 | 0.3 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.0 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.0 | 0.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.1 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.0 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.1 | GO:0004803 | transposase activity(GO:0004803) |
0.0 | 0.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 0.2 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.1 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.1 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.0 | 0.1 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.0 | 0.1 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 0.0 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.1 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.0 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.0 | 0.2 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.2 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.1 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.0 | 0.0 | GO:0030955 | potassium ion binding(GO:0030955) |
0.0 | 0.2 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.0 | GO:0032142 | single guanine insertion binding(GO:0032142) oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.0 | 0.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.1 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.0 | 0.4 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.0 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
0.0 | 0.4 | GO:0001948 | glycoprotein binding(GO:0001948) |
0.0 | 0.0 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.2 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.1 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.1 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.0 | 0.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.1 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.1 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.1 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
0.0 | 0.0 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 0.0 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) adenyl deoxyribonucleotide binding(GO:0032558) |
0.0 | 0.0 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.0 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.3 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.0 | 0.0 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.0 | 0.0 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.0 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.1 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 0.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.1 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.5 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.1 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.0 | 0.0 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.0 | 0.0 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.1 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.4 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.0 | 1.1 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.0 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.1 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.1 | GO:0001077 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.1 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 0.0 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.0 | 0.0 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.1 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.0 | 0.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.0 | 0.0 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.0 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.0 | GO:0043734 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.0 | 0.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.0 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
0.0 | 0.0 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.0 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 0.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 0.2 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 2.2 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 1.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 1.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.8 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.5 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.0 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.0 | 0.5 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.8 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.0 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 1.0 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.8 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 4.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.5 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.6 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.8 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.4 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.1 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.2 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 1.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.9 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 1.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 1.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 0.2 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.0 | 0.5 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.6 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.5 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.0 | 0.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 1.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.5 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.5 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.4 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.1 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.3 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.3 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.2 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.1 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.0 | 0.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.4 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.0 | 0.3 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.4 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.0 | 0.3 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.5 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.2 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.2 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.3 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.1 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.5 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.1 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.0 | 0.2 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 0.0 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.0 | 0.3 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.3 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 0.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.1 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.1 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.0 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.0 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.2 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
0.0 | 0.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.1 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.3 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 3.1 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |